Notable partnerships in aesthetic medicine include that of Candela and Jabil, Revance and HintMD, among others.
Hydrafacial and Vesper Healthcare recently announced they have entered into a definitive merger agreement expected to close in the first half of 2021.
FDA approvals in 2020 included Galderma’s Restylane Kysse, Endo Aesthetics QWO for cellulite, and more.
Revance Therapeutics announces positive phase 2 DAXI results and provides an update on expected FDA Approval.
InMode recently announced study results comparing fractional RF vs. Er:YAG plume for transmission risk of COVID-19.